“…It is estimated that during the 3-year period (2011–2014), more than 26,000 TAVI procedures had been performed at 348 centers in the USA with satisfactory patient outcomes. 5 However, despite the high safety and effectiveness of TAVI procedure in appropriately selected patients groups, 6 this therapeutic option has several periprocedural complications, including stroke, bleeding, vascular complications, acute kidney injury, requirement for permanent pacemaker (PPM) implantation, myocardial infarction, valve malposition, paravalvular leak and heart block. 7 , 8 In the currently available published research, several patient and technical-related factors have been associated with postprocedural complications such as advanced age, female gender, diabetes mellitus, poor left ventricular ejection fraction, peripheral arterial disease, access route, size of the delivery system, history of stroke, prior and/or a new-onset atrial fibrillation (NOAF), baseline severe aortic regurgitation, severity of calcifications on the valve and the aortic arch.…”